J
Jinwei Lei
Researcher at Chongqing Medical University
Publications - 7
Citations - 50
Jinwei Lei is an academic researcher from Chongqing Medical University. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 2, co-authored 6 publications receiving 7 citations.
Papers
More filters
Journal ArticleDOI
HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance.
Beige Zong,Lu Sun,Yang Peng,Yihua Wang,Yu Yu,Jinwei Lei,Yingzi Zhang,Shipeng Guo,Kang Li,Shengchun Liu +9 more
TL;DR: In this paper, the expression and biological significance of HORMAD1 in human triple-negative breast cancer (TNBC) was evaluated using reverse transcription-quantitative PCR (RPC) and western blot analysis.
Journal ArticleDOI
Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells
TL;DR: In this article, the serpin peptidase inhibitor SERPINA3 was found to be a potential marker associated with tumor progression in breast cancer, which is a critical target for the clinical treatment of BC.
Journal ArticleDOI
A look into the link between centrosome amplification and breast cancer
TL;DR: The mechanism of intracellular centrosome amplification, the impact of which on breast cancer and the latest breast cancer target treatment options for centrosomes are exhaustively elaborated in this review.
Journal ArticleDOI
Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer Patients
Yingkun Xu,Yang Peng,Mei-Chen Shen,Li Liu,Jinwei Lei,Shun Gao,Yan Wang,A Lan,Han Li,Shengchun Liu +9 more
TL;DR: A matching nomogram is drawn that can predict the 5, 7, and 10-year overall survival rates of BRCA patients and there is a significant correlation between the risk model and the patient's T and stage.
Journal ArticleDOI
KLHL5 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Gastric Cancer.
TL;DR: Elevated KLHL5 expression was found to be differentially expressed and correlated with clinical outcomes in several types of cancers in the TCGA database, indicating that KLHL 5 is a modulator in infiltrate recruitment, shaping the landscape of immune cell infiltration in different neoplasms.